Found: 12
Select item for more details and to access through your institution.
'Perhaps a Bit Different to What We Did Twenty Years Ago': Senior Teachers' Perceptions of Outdoor Adventure within Primary Education in England.
- Published in:
- Sports (2075-4663), 2019, v. 7, n. 4, p. 92, doi. 10.3390/sports7040092
- By:
- Publication type:
- Article
1478. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S539, doi. 10.1093/ofid/ofz360.1342
- By:
- Publication type:
- Article
2722 B. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S960, doi. 10.1093/ofid/ofz360.2406
- By:
- Publication type:
- Article
A Review of Meningococcal Disease and Vaccination Recommendations for Travelers.
- Published in:
- Infectious Diseases & Therapy, 2018, v. 7, n. 2, p. 219, doi. 10.1007/s40121-018-0196-z
- By:
- Publication type:
- Article
Candidate odours for a short form odorant identification test.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2013, v. 270, n. 10, p. 2663, doi. 10.1007/s00405-013-2373-8
- By:
- Publication type:
- Article
A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 1, p. 1, doi. 10.1093/cid/ciz153
- By:
- Publication type:
- Article
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 1, p. 42, doi. 10.1093/cid/ciy009
- By:
- Publication type:
- Article
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 5, p. 787, doi. 10.1093/cid/cix419
- By:
- Publication type:
- Article
A SUMMARY OF MĀORI ISSUES FOR DISASTER RECOVERY IN THE ENVIRONMENTAL HEALTH FIELD.
- Published in:
- Pimatisiwin: A Journal of Aboriginal & Indigenous Community Health, 2011, v. 9, n. 1, p. 23
- By:
- Publication type:
- Article
A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 2, p. 367, doi. 10.1093/infdis/jiad307
- By:
- Publication type:
- Article
Adipocyte Enhancer-Binding Protein 1 Modulates Adiposity and Energy Homeostasis.
- Published in:
- Obesity (19307381), 2007, v. 15, n. 2, p. 288, doi. 10.1038/oby.2007.569
- By:
- Publication type:
- Article